United States· US:50419-542_28aa9af2-2939-46e0-8c9c-af939e81b551
Kerendia
A finerenone product containing finerenone, registered in United States by Bayer HealthCare Pharmaceuticals Inc.. The same ATC class is registered in 15 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Finerenone is registered in 15 of 19 countries.
Countries holding a registration under ATC C03DA05 (finerenone), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Finerenone · ATC C03DA05
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of finerenone costs, country by country.
Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Finerenone · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- IT Italy$5.64
- CH Switzerland$4.82
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- FINERENONE
- Manufacturer
- Bayer HealthCare Pharmaceuticals Inc.
- Country
- United States (US)
- ATC code
- C03DA05
- ATC class
- Finerenone
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 8
- ndc11504195420130 TABLET in 1 BOTTLE, PLASTIC (50419-542-01)
- ndc11504195420290 TABLET in 1 BOTTLE, PLASTIC (50419-542-02)
- ndc11504195420610 TABLET in 1 BLISTER PACK (50419-542-06)
- ndc1150419542707 TABLET in 1 BOTTLE, PLASTIC (50419-542-70)
- ndc1150419-542-01
- ndc1150419-542-02
- ndc1150419-542-06
- ndc1150419-542-70
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Finerenone in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomKerendia 40mg tabletsBayer Plc
- CzechiaKERENDIABayer AG, Leverkusen
- FinlandKerendiaBayer AG
- SwitzerlandKerendia
- NetherlandsKerendia 10 mg filmomhulde tablettenBayer AG
- IcelandKerendiaBayer AG*
- BelgiumKerendia 10 mgBayer
- SpainKERENDIA 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULABayer Ag
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Kerendia
- Liechtenstein · Kerendia
- Norway · Kerendia
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/27ee9ef2-d549-45a4-a5a7-4b687e5dbd68 GET /v1/drugs/27ee9ef2-d549-45a4-a5a7-4b687e5dbd68?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "40",
"substance": "FINERENONE",
"productndc": "50419-542",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA215341",
"marketing_category": "NDA"
}See everything about finerenone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.